State Street SPDR S&P Pharmaceuticals ETF (XPH) — ETF Analysis on Winston
Key Facts
- Issuer: SPDR
- Category: Equity
- Asset Class: Equity
- Price: $68.60
- Expense Ratio: 35.00%
- Assets Under Management: $422M
- Number of Holdings: 65
- Inception Date: 2006-06-19
- Currency: USD
Winston Score
State Street SPDR S&P Pharmaceuticals ETF has a Winston Score of 68 out of 100.
Performance
- 1-Year Return: 41.94%
- 3-Year Return: 37.75%
- 5-Year Return: 14.98%
Top Holdings
ENLIVEN THERAPEUTICS INC (N/A%), ORGANON + CO (N/A%), CORCEPT THERAPEUTICS INC (N/A%), TREVI THERAPEUTICS INC (N/A%), DEFINIUM THERAPEUTICS INC (N/A%)
Sector Breakdown
Healthcare (N/A%)